Skip to content
Riskpilot
← Back to search
Sign in
Get full access
AMPLEXA GENETICS A/S
A/S
Active
CVR 29428441
Sverigesgade 24, 5000
Odense C
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2006 · 20 years old
12 employees
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
AMPLEXA GENETICS A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PC
P&F CONSECO
Founder
Founder
2006
Former (3)
KB
Klaus Brusgaard
Management
Management
2006 – 2011
HA
Hans Atli Eli Albinus Dahl
Chief Executive Officer
Chief Executive Officer
2011 – 2018
HH
Helle Hjalgrim
Chief Executive Officer
Chief Executive Officer
2018 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
ER
Eydfinn Reydberg
Board of Directors
Board of Directors
2011
MH
Magnus Herdalur
Chairman
Chairman
2026
UB
Ulf Bech Christensen
Board of Directors
Board of Directors
2023
Former (10)
LM
Leif Mosekilde
Board of Directors
Board of Directors
2013 – 2015
CS
Charles Steven Glavas
Board of Directors
Board of Directors
2018 – 2023
JJ
Johan Jan Albinus Dahl
Chairman
Chairman
2015 – 2026
NC
Nils Christian Jensen
Board of Directors
Board of Directors
2013 – 2023
LA
Leif Abrahamsen
Board of Directors
Board of Directors
2018 – 2023
AS
Andras Splidt
Board of Directors
Board of Directors
2008 – 2009
JK
Jørn Kildegaard Andersen
Chairman
Chairman
2013 – 2015
PM
Pál Magni Weihe
Board of Directors
Board of Directors
2009 – 2018
MR
Marita Rasmussen
Board of Directors
Board of Directors
2006 – 2010
JD
Johan Dahl
Board of Directors
Board of Directors
2006 – 2008
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Sp/f D65 Holding
Individual
33.33–49.99%
33.33–49.99%
2024
SCIENT. INVEST ApS
Company
33.33–49.99%
33.33–49.99%
2024
Conseco P/F
Individual
25–33.32%
25–33.32%
2023
P/f Norðoya Íløgufelag
Individual
20–24.99%
20–24.99%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AMPLEXA GENETICS A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network